Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

  • The PLOS ONE Staff

Notice of republication

An incorrect version of Fig 1 was published in error. The publisher apologizes for the error. This article was republished on June 1, 2021, to correct for this error. Please download this article again to view the correct version.

Reference

  1. 1. Mohamed Amine M, Selma M, Adel S, Khaoula Bha, Mohamed Hassene K, Imen T, et al. (2021) 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLoS ONE 16(5): e0251716. https://doi.org/10.1371/journal.pone.0251716 pmid:34015041

Citation: The PLOS ONE Staff (2021) Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLoS ONE 16(6): e0253252. https://doi.org/10.1371/journal.pone.0253252

Published: June 9, 2021

Copyright: © 2021 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.